Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
400mg/vial
|
|||
Strength
400mg/syringe
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Abilify Maintena (Aripiprazole) is an antipsychotic medication used to treat adults with schizophrenia and bipolar disorder. It works by balancing the dopamine and serotonin levels in the brain, which may help improve thoughts, mood, and behavior. As a once-monthly injectable drug, Abilify Maintena may help simplify treatment plans while maintaining consistent results.
Fact Table | |
Formula |
C23H27Cl2N3O2 |
License |
US FDA, EU EMA, US DailyMed |
Bioavailability |
87% |
Legal status |
Rx-only |
Chemical Name |
Aripiprazole |
Elimination half-life |
75 hours |
Dosage (Strength) |
400mg Maintena |
Pregnancy |
Consult Doctor |
Brands |
Abilify Maintena |
Protein binding |
99% |
PubChem CID |
60795 |
MedlinePlus |
a603012 |
ChEBI |
31236 |
ATC code |
N05AX12 |
DrugBank |
DB01238 |
KEGG |
D01164 |
Routes of administration |
Intramuscular |
Abilify Maintena (Aripiprazole) is an extended-release injection administered by a healthcare provider, typically at a doctor's office or a hospital. The standard recommended Abilify Maintena dosing is 400 mg once monthly. For those without a history of Aripiprazole use, it is necessary to establish tolerability with oral Aripiprazole for up to two weeks before starting treatment with the injection. The injection is administered in either the shoulder or buttocks.
The main ingredient in Abilify Maintena is Aripiprazole, which belongs to the class of atypical antipsychotics. The injectable suspension of Abilify Maintena may contain inactive ingredients to preserve and stabilize the medication.
Contraindications
Those who have experienced an allergic reaction or hypersensitivity to Aripiprazole or any of the ingredients found in the Abilify Maintena injection should avoid using the medication.
Abilify Maintena may cause side effects. The most common Abilify Maintena side effects may include inner restlessness (akathisia), drowsiness, weight gain, and pain at the injection site. Other side effects may vary. Consult a healthcare provider if side effects develop, persist, or worsen.
More serious side effects of Abilify Maintena may require immediate medical attention. These can include an increased risk of stroke and ministroke, especially in elderly people with dementia-related psychosis, and neuroleptic malignant syndrome (NMS), a serious condition that can potentially lead to death. If someone taking Abilify Maintena experiences any of these severe side effects, it is crucial to seek medical advice promptly.
References:
Abilify Maintena (Aripiprazole) Highlights of Prescribing Information. Tokyo, JP: Otsuka America Pharmaceutical, Inc; 2023.